Author:
Corpechot Christophe,Poupon Raoul,Chazouillères Olivier
Subject
Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Setanaxib, a first‐in‐class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo‐controlled, phase 2 trial;Liver International;2023-05-15
2. PPAR agonists for the treatment of primary biliary cholangitis: Old and new tales;Journal of Translational Autoimmunity;2023
3. Evaluation and Management of Pruritus in Primary Biliary Cholangitis;Clinics in Liver Disease;2022-11
4. Feasibility, safety and tolerability of the CREB-binding protein/β-catenin inhibitor OP-724 in patients with advanced primary biliary cholangitis: an investigator-initiated, open-label, non-randomised, two-centre, phase 1 study;BMJ Open Gastroenterology;2022-11
5. A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis;Journal of Hepatology;2022-08